TBI Form 4: CEO/Director Disposes 1,436 Shares at $6.06

Rhea-AI Filing Summary

Insider sale by TrueBlue CEO/President and Director. The filing shows that Taryn R. Owen, who serves as CEO and President and a director, reported a sale of 1,436 shares of TrueBlue, Inc. (TBI) on 10/03/2025 at a price of $6.06 per share. After this transaction she beneficially owns 411,024 shares.

The Form 4 was signed by an attorney-in-fact on 10/07/2025. The report is a routine Section 16 disclosure showing a non-derivative disposition of common stock; no derivative transactions or additional remarks are reported in Table II or the explanation section.

Positive

• Disclosure compliance: The reporting person filed a timely Form 4 with transaction details
• Modest sale size: Only 1,436 shares were sold, leaving 411,024 shares owned

Negative

• None.

Insights

Corporate Governance Analyst

Routine insider sale by CEO/Director; modest in scale relative to total holdings.

The reported transaction is a disposition of 1,436 common shares executed on 10/03/2025 at $6.06 per share, leaving the reporting person with 411,024 shares. This filing is a standard Section 16 disclosure that updates public records of insider ownership and trading.

The primary dependency for interpretation is scale: the sale amount is small compared with the remaining 411,024 shares, which suggests this is not a major change in ownership. Monitor future Form 4s for any pattern of sales within the next 90–180 days that would indicate a material change in insider disposition behavior.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Owen Taryn R

(Last) (First) (Middle)

1015 A STREET

(Street)

TACOMA WA 98402

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TrueBlue, Inc. [ TBI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO and President

3. Date of Earliest Transaction (Month/Day/Year)
10/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/03/2025		F		1,436	D	$6.06	411,024	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Todd N. Gilman, Attorney-in-fact	10/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Taryn R. Owen sell as reported on the TBI Form 4?

She disposed of 1,436 shares of TrueBlue common stock on 10/03/2025 at $6.06 per share.

How many TrueBlue (TBI) shares does the reporting person own after the sale?

The filing reports beneficial ownership of 411,024 shares following the reported transaction.

When was the Form 4 for TBI signed and filed?

The form was signed by an attorney-in-fact on 10/07/2025.

Does the Form 4 report any derivative transactions for TBI?

No. Table II shows no derivative securities acquired or disposed; only a non-derivative sale is reported.

What is the reporting person's role at TrueBlue (TBI)?

The reporting person is listed as a Director and as CEO and President.